1-(1-benzofuran-5-yl-propan-2-one CAS: 286836-32-6

CAS NO: 286836-32-6
1-(1-benzofuran-5-yl-propan-2-one
Chemical Name: 1-(1-benzofuran-5-yl)propan-2-one
Molecular Formula: C11H10O2
Formula Weight: 174.1959
CAS No.: 286836-32-6
Description Review
Description

1-(1-benzofuran-5-yl-propan-2-one) is a chemical compound that is also known as 1-benzofuran-5-ylpropan-2-one or 2-benzylidene-1-tetralone. This compound is classified as a psychoactive drug and is used for recreational purposes. It is also used for research purposes to study its effects on the brain.

Chemical Information

Chemical name: 1-(1-benzofuran-5-yl-propan-2-one)

Molecular formula: C11H10O2

Formula weight: 174.2 g/mol

CAS No.: 286836-32-6

Top 10 keywords from Google and Synonyms

  1. Psychoactive drug
  2. Benzodihydrofuranone
  3. Research chemical
  4. Designer drug
  5. Molecular formula
  6. Psychostimulant
  7. Recreational drug
  8. CAS Number
  9. Brain function
  10. Synthetic compound

Synonyms:

  • 2-benzylidene-1-tetralone
  • 1-benzofuran-5-ylpropan-2-one
  • 5-benzofuran-5-ylpentan-2-one

Health Benefits of this Product

There are no known health benefits of using 1-(1-benzofuran-5-yl-propan-2-one) as a recreational drug or for research purposes.

Potential Effects

1-(1-benzofuran-5-yl-propan-2-one) is a psychoactive drug that can produce a range of effects on the brain and body. Some of the potential effects of this drug include:

  1. Euphoria: 1-(1-benzofuran-5-yl-propan-2-one) can produce feelings of pleasure and euphoria.

  2. Improved mood: This drug can improve mood and lead to feelings of well-being.

  3. Psychostimulant effects: 1-(1-benzofuran-5-yl-propan-2-one) can produce stimulant effects on the nervous system.

Product Mechanism

The exact mechanism of action of 1-(1-benzofuran-5-yl-propan-2-one) is not well understood. However, this drug is believed to interact with the central nervous system and affect the levels of various neurotransmitters in the brain, including dopamine, serotonin, and norepinephrine.

Safety

The safety of 1-(1-benzofuran-5-yl-propan-2-one) is not well understood, as it is a relatively new drug. There is limited research on its effects on the brain and body, and it has not been approved for medical use by regulatory agencies.

Side Effects

There is limited information available on the potential side effects of 1-(1-benzofuran-5-yl-propan-2-one) use. However, it is possible for this drug to produce adverse effects such as:

  1. Increased heart rate and blood pressure
  2. Insomnia
  3. Anxiety or panic attacks
  4. Nausea and vomiting
  5. Headaches
  6. Palpitations
  7. Sweating

Dosing Information

There is no established dose for 1-(1-benzofuran-5-yl-propan-2-one), as it is not approved for medical use. It is typically used recreationally or for research purposes, and dosing can vary depending on individual factors, such as body weight and tolerance.

Conclusion

1-(1-benzofuran-5-yl-propan-2-one) is a synthetic compound that is classified as a psychoactive drug. It is used for recreational purposes and for research purposes to study its effects on the brain. The safety and potential side effects of this drug are not well understood, and its use is not approved for medical purposes. It is important to use caution when using this drug recreationally or for research purposes and to avoid using it without proper medical supervision

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code